Pharming (PHAR) Change in Cash (2019 - 2025)

Pharming's Change in Cash history runs 7 years deep, the most recent figure standing at $11.7 million for Q4 2025.

• Quarterly Change in Cash rose 354.94% year-over-year to $11.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$128.0 million (up 32.34% YoY) and the FY2025 annual result came in at $82.5 million, up 1896.77% from the prior year.
• Change in Cash was $11.7 million for Q4 2025 at Pharming, up from -$4.6 million in the prior quarter.
• Across five years, Change in Cash topped out at $12.7 million in Q3 2024 and bottomed at -$147.7 million in Q4 2023.
• A 5-year average of -$27.7 million and a median of -$3.6 million in 2022 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2021 — Change in Cash surged 1475.81% — and 2023, when it slumped 5464.18%.
• Pharming's Change in Cash stood at $2.1 million in 2021, then slumped by 225.47% to -$2.7 million in 2022, then slumped by 5464.18% to -$147.7 million in 2023, then surged by 96.89% to -$4.6 million in 2024, then surged by 354.94% to $11.7 million in 2025.
• Business Quant data shows PHAR's Change in Cash at $11.7 million in Q4 2025, -$4.6 million in Q4 2024, and $12.7 million in Q3 2024.